Ли Ноу - Эгоистичная митохондрия. Как сохранить здоровье и отодвинуть старость
- Название:Эгоистичная митохондрия. Как сохранить здоровье и отодвинуть старость
- Автор:
- Жанр:
- Издательство:Питер
- Год:2020
- Город:Санкт-Петербург
- ISBN:978-5-4461-1021-6
- Рейтинг:
- Избранное:Добавить в избранное
-
Отзывы:
-
Ваша оценка:
Ли Ноу - Эгоистичная митохондрия. Как сохранить здоровье и отодвинуть старость краткое содержание
В нашем организме работают крошечные «энергетические станции» — митохондрии. Именно они отвечают за наше здоровье и отличное самочувствие. Когда они работают хорошо, мы не испытываем недостатка в энергии. А когда плохо — страдаем от заболеваний. Доктор Ли Ноу открывает тайну: заболевания, которые кажутся не связанными между собой на первый взгляд: диабет, рак, шизофрения, хроническая усталость, болезнь Паркинсона и другие — имеют общую природу.
Сегодня нам известно, как улучшить работу митохондрий, обеспечивающих организм энергией на 90 %. В этой книге вас ждет актуальная информация о питании, образе жизни, кетогенной диете и добавках, которые возвращают здоровье митохондриям, а следовательно, и нам.
Эгоистичная митохондрия. Как сохранить здоровье и отодвинуть старость - читать онлайн бесплатно ознакомительный отрывок
Интервал:
Закладка:
Neustadt J., Pieczenik S. R. Medication-induced mitochondrial damage and disease. Mol Nutr Food Res. 2008 Jul; 52(7):780–8. doi:10.1002/ mnfr.200700075.
Olsen E. A., Brambrink A. M. Anesthetic neurotoxicity in the newborn and infant. Curr Opin Anaesthesiol. 2013 Oct; 26(5):535–42. Epub 2013 Aug 29. doi:10.1097/01.aco.0000433061.59939.b7.
Reid A. B., et al. Mechanisms of acetaminophen-induced hepatotoxicity: role of oxidative stress and mitochondrial permeability transition in freshly isolated mouse hepatocytes. J Pharmacol Exp Ther. 2005 Feb; 312(2):509–16. doi:10.1124/jpet.104.075945.
Roberton A. M., Ferguson L. R., Cooper G. J. Biochemical evidence that high concentrations of the antidepressant amoxapine may cause inhibition of mitochondrial electron transport. Toxicol Appl Pharmacol. 1988 Mar 30; 93(1):118–26. doi:10.1016/0041-008X(88)90031-2.
Shah N. L., Gordon F. D. N-acetylcysteine for acetaminophen overdose: when enough is enough. Hepatology. 2007 Sep; 46(3):939–41.
Sirvent P., et al. Simvastatin induces impairment in skeletal muscle while heart is protected. Biochem Biophys Res Commun. 2005 Dec 23; 338(3):1426–34. doi:10.1016/j.bbrc.2005.10.108.
Sirvent P., et al. Simvastatin triggers mitochondria-induced Ca2+ signaling alteration in skeletal muscle. Biochem Biophys Res Commun. 2005 Apr 15;329(3):1067–75. doi:10.1016/j.bbrc.2005.02.070.
Souza M. E., et al. Effect of fluoxetine on rat liver mitochondria. Biochem Pharmacol. 1994 Aug 3; 48(3):535–41. doi:10.1016/0006-2952(94)90283-6.
Vaughan R. A., et al. Ubiquinol rescues simvastatin-suppression of mitochondrial content, function and metabolism: implications for statin-induced rhabdomyolysis. Eur J Pharmacol. 2013 Jul 5; 711(1–3):1–9. Epub 2013 Apr 24. doi:10.1016/j.ejphar.2013.04.009.
Velho J. A., et al. Statins induce calcium-dependent mitochondrial permeability transition. Toxicology. 2006 Feb; 219(1–3):124–32.
Wang M. Y., Sadun A. A. Drug-related mitochondrial optic neuropathies. J Neuroophthalmol. 2013 Jun;33(2):172–8. doi:10.1097/ WNO.0b013e3182901969.
Westwood F. R., et al. Statin-induced muscle necrosis in the rat: distribution, development, and fibre selectivity. Toxicol Pathol. 2005; 33(2):246–57. doi:10.1080/01926230590908213.
Xia Z., et al. Changes in the generation of reactive oxygen species and in mitochondrial membrane potential during apoptosis induced by the antidepressants imipramine, clomipramine, and citalopram and the effects on these changes by Bcl-2 and BclX(L). Biochem Pharmacol. 1999 May 15; 57(10):1199–208.
Xue S. Y., et al. Nucleoside reverse transcriptase inhibitors induce a mitophagy-associated endothelial cytotoxicity that is reversed by coenzyme Q10 cotreatment. Toxicol Sci. 2013 Aug;134(2):323–34. Epub 2013 May 2. doi:10.1093/toxsci/kft105.
Yousif W. Microscopic studies on the effect of alprazolam (Xanax) on the liver of mice. Pak J Biol Sci. 2002; 5(11):1220–5. doi:10.3923/ pjbs.2002.1220.1225.
Zhao C., Shichi H. Prevention of acetaminophen-induced cataract by a combination of diallyl disulfide and N-acetylcysteine. J Ocul Pharmacol Ther. 1998 Aug; 14(4):345–55. doi:10.1089 /jop.1998.14.345.
Bainbridge, L. Understanding and coping with mitochondrial disease. Hamilton, ON: Hamilton Health Sciences; 2010.
Bertini E., D’Amico A. Mitochondrial encephalomyopathies and related syndromes [review]. Endocr Dev. 2009; 14:38–52.
Debray F. G., Lambert M., Mitchell G. A. Disorders of mitochondrial function. Curr Opin Pediatr. 2008 Aug; 20(4):471–82. doi:10.1097/ MOP.0b013e328306ebb6.
DiMauro S., Schon E. A. Mitochondrial respiratory-chain diseases. N Engl J Med. 2003 Jun; 348(26):2656–68. doi:10.1056/NEJMra022567.
DiMauro S., et al. Diseases of oxidative phosphorylation due to mtDNA mutations. Semin Neurol. 2001 Sep; 21(3):251–60. doi:10.1055/s-2001-17942. Finsterer J. Leigh and Leigh-like syndrome in children and adults. Pediatr Neurol. 2008 Oct; 39(4):223–35. doi:10.1016/j.pediatrneurol.2008.07.013.
Folkers K., Simonsen R. Two successful double-blind trials with coenzyme Q10 (vitamin Q10) on muscular dystrophies and neurogenic atrophies. Biochim Biophys Acta. 1995 May 24; 1271(1):281–6.
Goldstein A. C., Bhatia P., Vento J. M. Mitochondrial disease in childhood: nuclear encoded. Neuro-therapeutics. 2013 Apr; 10(2):212–26. Epub Mar 21 2013. doi:10.1007/s13311-013-0185-6.
Kisler J. E., Whittaker R. G., McFarland R. Mitochondrial diseases in childhood: a clinical approach to investigation and management. Dev Med Child Neurol. 2010 May; 52(5):422–33. doi:10.1111/j.1469–8749.2009.03605.x.
Koenig M. K. Presentation and diagnosis of mitochondrial disorders in children. Pediatr Neurol. 2008 May; 38(5):305–13. doi:10.1016/j.pediatr-neurol.2007.12.001.
Li H., et al. Comparative bioenergetic study of neuronal and muscle mitochondria during aging. Free Radic Biol Med. 2013 Oct; 63:30–40. Epub Apr 30 2013. doi:10.1016/j.freeradbiomed.2013.04.030.
Lodi R., et al. Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich’s ataxia. Ann Neurol. 2001 May 1; 49(5):590–6. doi:10.1002/ana.1001.
McFarland R., Taylor R. W, Turnbull D. M. A neurological perspective on mitochondrial disease. Lancet Neurol. 2010 Aug; 9(8):829–840. doi:10.1016/S1474-4422(10)70116-2.
Siciliano G., et al. Functional diagnostics in mitochondrial diseases. Biosci Rep. 2007 Jun; 27(1–3):53–67. doi:10.1007/s10540-007-9037-0.
Sproule D. M., Kaufmann P. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann NY Acad Sci. 2008 Oct; 1142:133–58. doi:10.1196/annals.1444.011.
Tarnopolsky M. A, Raha S . Mitochondrial myopathies: diagnosis, exercise intolerance, and treatment options. Med Sci Sports Exerc. 2005 Dec; 37(12):2086–93.
Taylor R. W., Turnbull D. M. Mitochondrial DNA mutations in human disease. Nat Rev Genet. 2005 May; 6(5):389–402. doi:10.1038/nrg1606.
Thorburn D. R. Mitochondrial disorders: prevalence, myths and advances. J Inherit Metab Dis. 2004; 27(3):349–62. doi:10.1023/ B: BOLI.0000031098.41409.55.
Tuppen H. A., et al. Mitochondrial DNA mutations and human disease. Biochim Biophys Acta. 2010 Feb; 1797(2):113–28. doi:10.1016/j.bba-bio.2009.09.005.
Uitto J., Bernstein E. F. Molecular mechanisms of cutaneous aging: connective tissue alterations in the dermis. J Investig Dermatol Symp Proc. 1998 Aug; 3(1):41–4.
Waller J. M., Maibach H. I. Age and skin structure and function, a quantitative approach (II): protein, glycosaminoglycan, water, and lipid content and structure. Skin Res Technol. 2006 Aug; 12(3):145–54. doi:10.1111/j.0909752X.2006.00146.x.
Bai U., et al. Mitochondrial DNA deletions associated with aging and possibly presbycusis: a human archival temporal bone study. Am J Otol. 1997 Jul;18(4):449–53.
Chen F. Q., et al. Mitochondrial peroxiredoxin 3 regulates sensory cell survival in the cochlea. PLoS One. 2013 Apr 23; 8(4):e61999. doi:10.1371/ journal.pone.0061999.
Dahl H. H., et al. Etiology and audiological outcomes at 3 years for 364 children in Australia. PLoS One. 2013;8(3):e59624. Epub 2013 Mar 28. doi:10.1371/journal.pone.0059624.
Ding Y., et al. The role of mitochondrial DNA mutations in hearing loss. Biochem Genet. 2013 Aug;51(7–8):588–602. Epub Apr 21 2013. doi:10.1007/s10528-013-9589-6.
Granville D. J., Gottlieb R. A. Mitochondria: Regulators of cell death and survival. Scientific World Journal. 2002 Jun 11; 2:1569–78. doi:10.1100/ tsw.2002.809.
Han C., Someya S. Maintaining good hearing: calorie restriction, Sirt3, and glutathione. Exp Gerontol. 2013 Oct 1; 48(10):1091–5. Epub 2013 Feb 20. doi:10.1016/j.exger.2013.02.014. Johnsson L. G., Hawkins J. E. Jr. Vascular changes in the human inner ear associated with aging. Ann Otol Rhinol Laryngol. 1972 Jun; 81(3):364–76. doi:10.1177/000348947208100307.
Komlosi K., et al. Non-syndromic hearing impairment in a Hungarian family with the m.7510T>C mutation of mitochondrial tRNA(Ser(UCN)) and review of published cases. JIMD Rep. 2013; 9:105–11. Epub 2012 Nov 2. doi:10.1007/8904_2012_187.
Lin F. R., et al. Hearing loss and cognitive decline in older adults. JAMA Intern Med. 2013; 173(4):293–9. doi:10.1001/jamainternmed.2013.1868. Luo L. F., Hou C. C., Yang W. X. Nuclear factors: roles related to mitochondrial deafness. Gene. 2013 May 15;520(2):79–89. Epub 2013 Mar 17. doi:10.1016/j.gene.2013.03.041.
Miller J. M., Marks N. J., Goodwin P. C. Laser Doppler measurements of cochlear blood flow. Hearing Res. 1983 Sep;11(3):385–94.
Seidman M. D. Effects of dietary restriction and antioxidants on presbycusis. Laryngoscope. 2000 May;110(5 pt 1):727–38. doi:10.1097/00005537-200005000-00003.
Seidman M. D., et al. Age related differences in cochlear microcirculation and auditory brain stem responses. Arch Otolaryngol Head Neck Surg. 1996 Nov; 122(11):1221–6. doi:10.1001 /archotol.1996.01890230067013. Seidman M. D., et al. Mitochondrial DNA deletions associated with aging and presbycusis. Arch Otolaryngol Head Neck Surg. 1997 Oct; 123(10):1039–45.
Seidman M. D., et al. Biologic activity of mitochondrial metabolites on aging and age-related hearing loss. Am J Otol. 2000 Mar; 21(2):161–7.
Seidman M. D., Moneysmith M. Save your hearing now. New York: Warner Books; 2006.
Semsei I., Rao G., Richardson A. Changes in the expression of superoxide dismutase and catalase as a function of age and dietary restriction. Biochem Biophys Res Commun. 1989 Oct 31; 164(2):620–5. doi:10.1016/0006-291X(89)91505-2.
Wallace D. C. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science. 1992 May 1; 256(5057):628–32. doi:10.1126/ science.1533953.
Yamasoba T., et al. Current concepts in age-related hearing loss: epidemiology and mechanistic pathways. Hear Res. 2013 Sep;303:30–8. Epub 2013 Feb 16. doi:10.1016/j.heares.2013.01.021.
Yelverton J. C., et al. The clinical and audiologic features of hearing loss due to mitochondrial mutations. Otolaryngol Head Neck Surg. 2013 Jun; 148(6):1017–22. Epub 2013 Mar 22. doi:10.1177/0194599813482705.
Balin A. K., Pratt L. A. Physiological consequences of human skin aging. Cutis. 1989 May; 43(5):431–6.
Blatt T., et al. Stimulation of skin’s energy metabolism provides multiple benefits for mature human skin. Biofactors. 2005; 25(1–4):179–85. doi:10.1002/biof.5520250121.
Greco M., et al. Marked aging-related decline in efifciency of oxidative phosphorylation in human skin fibroblasts. FASEB J. 2003 Sep;17(12):1706–8. doi:10.1096/fj.02-1009fje.
Kagan J., Srivastava S. Mitochondria as a target for early detection and diagnosis of cancer. Crit Rev Clin Lab Sci. 2008; 42(5–6):453–72. doi:10.1080/10408360500295477.
Kleszczynski K., Fischer T. W. Melatonin and human skin aging. Dermatoendocrinol. 2012 Jul 1; 4(3):245–52. doi:10.4161/derm.22344.
Читать дальшеИнтервал:
Закладка:
